0001209191-19-060662.txt : 20191216
0001209191-19-060662.hdr.sgml : 20191216
20191216163501
ACCESSION NUMBER: 0001209191-19-060662
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191213
FILED AS OF DATE: 20191216
DATE AS OF CHANGE: 20191216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yanni Barbara
CENTRAL INDEX KEY: 0001610561
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 191287576
MAIL ADDRESS:
STREET 1: 1018 W. 8TH AVENUE
STREET 2: SUITE A
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-207-0202
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-13
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001610561
Yanni Barbara
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON
MA
02210
1
0
0
0
Stock Option (right to buy)
19.30
2019-12-13
4
A
0
53000
0.00
A
2029-12-12
Common Stock
53000
53000
D
The shares vest over a four year period in equal annual installments beginning on December 13, 2019.
/s/ Joshua F. Patterson, Attorney-in-Fact
2019-12-16